Impact of Acyclovir on Genital and Plasma HIV‐1 RNA, Genital Herpes Simplex Virus Type 2 DNA, and Ulcer Healing among HIV‐1–Infected African Women with Herpes Ulcers: A Randomized Placebo‐Controlled Trial
Author(s) -
Philippe Mayaud,
Jérôme LeGoff,
Helen A. Weiss,
Gérard Grésenguet,
Nzambi Khonde,
Hicham Bouhlal,
Éric Frost,
JeanLouis Pépin,
JeanElie Malkin,
Richard Hayes,
David Mabey,
Laurent Bélec
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/599991
Subject(s) - herpes simplex virus , medicine , genital ulcer , placebo , virology , sex organ , rna , virus , gastroenterology , relative risk , randomized controlled trial , immunology , confidence interval , human immunodeficiency virus (hiv) , sexually transmitted disease , biology , pathology , biochemistry , alternative medicine , syphilis , gene , genetics
Little is known about the impact of episodic treatment of herpes on human immunodeficiency virus type 1 (HIV-1).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom